Kang Stem Biotech receives final clinical report for 'Oscar' trial, says 'consistency of key results confirmed'
Predicted impact: Low
Final clinical trial report receipt; results described only as consistent, with no size given.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.